These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biotech battle royale. Two firms fight over billion-dollar drug. Sherrid P US News World Rep; 2000 Mar; 128(11):52. PubMed ID: 10848209 [No Abstract] [Full Text] [Related]
5. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
6. Japanese firms broaden investment focus to early biotech. Louët S; Sipp D Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631 [No Abstract] [Full Text] [Related]
7. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
8. Perspective: Biotech funding trends: Insights from entrepreneurs and investors. Gruber AC Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460 [TBL] [Abstract][Full Text] [Related]
9. Today's biotech industry in India. Suresh N Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434 [No Abstract] [Full Text] [Related]
10. Biotech companies adapt to big pharma mergers. Niiler E Nat Biotechnol; 2000 May; 18(5):487-8. PubMed ID: 10802607 [No Abstract] [Full Text] [Related]
11. Biotechnology. Drug firms wary of health bill. Wagner M Mod Healthc; 1988 Apr; 18(18):42. PubMed ID: 10287265 [No Abstract] [Full Text] [Related]
12. Public biotech 98: the numbers. Lähteenmäki R; Michael A; Marshall A Nat Biotechnol; 1999 May; 17(5):429-32. PubMed ID: 10331795 [No Abstract] [Full Text] [Related]
13. Overcoming further challenges in the pharma/biotech industry: 2007 update. Graul AI; Cruces E; Revel L; Serradell N; Rosa E Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809 [TBL] [Abstract][Full Text] [Related]
14. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
16. Biotech R&D goes further afield. Lawrence S Nat Biotechnol; 2006 Sep; 24(9):1052. PubMed ID: 16964201 [No Abstract] [Full Text] [Related]
17. Biotech R&D still reeling. Lawrence S Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460 [No Abstract] [Full Text] [Related]
18. The development of China's medical biotech industry needs to be driven by innovation. Yu Z; Dai Y Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752 [TBL] [Abstract][Full Text] [Related]
19. Editorial: Biotech in the financial crisis. Jungbauer A Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457 [No Abstract] [Full Text] [Related]